+30.4%
GSK vs TENB
+11.6%
+18.8%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -0.7% | -1.2% | -2.0% |
| 7D | -1.8% | -9.1% | +7.2% | -2.6% |
| 30D | -2.2% | -4.9% | +2.7% | -2.4% |
| 3M | -1.8% | +16.9% | -18.7% | +0.1% |
| 6M | -10.6% | +68.0% | -78.6% | -5.3% |
| YTD | +4.4% | +45.6% | -41.1% | +9.2% |
| 1Y | +30.4% | +12.7% | +17.7% | +27.6% |
| All | +30.4% | +11.6% | +18.8% | +27.6% |
Cumulative growth
Daily Returns
Daily percentage return beside TENB.
Daily Out/Under-Performance
Portfolio return minus TENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling